Company

Verrica Pharmaceuticals Inc.

Headquarters: West Chester, PA, United States

Employees: 38

CEO: Mr. Ted White

NASDAQ: VRCA +2.66%

Market Cap

$317.1 Million

USD as of July 1, 2024

Market Cap History

Verrica Pharmaceuticals Inc. market capitalization over time

Evolution of Verrica Pharmaceuticals Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Verrica Pharmaceuticals Inc.

Detailed Description

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and which is in Phase II clinical trial for treating common warts. It is also developing cantharidin-based product candidate, VP-103 for treating plantar warts. The company has a license and collaboration agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum contagiosum and common warts in Japan, including VP-102; and a license agreement with Lytix Biopharma AS to develop and commercialize LTX-315 for dermatological oncology indications. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Verrica Pharmaceuticals Inc. has the following listings and related stock indices.


Stock: NASDAQ: VRCA wb_incandescent

Stock: FSX: 1NE wb_incandescent

Details

Headquarters:

10 North High Street

Suite 200

West Chester, PA 19380

United States

Phone: 484 453 3300